feedback
facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Recalled Product

Item detail and remedy information

Search Recalls or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Home > Recalled Products > Drugs > Lack of FDA Approval > VitaliKOR Dietary Supplement for Sexual Enhancement

Recall: VitaliKOR Dietary Supplement for Sexual Enhancement

email
email

On 2013-11-14, the FDA announced that Vitality Research Labs is conducting a recall on Dietary Supplement for Sexual Enhancement due to a possible lack of fda approval. The recalled products were sold under the brand name(s) VitaliKOR during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 3 drugs recalls due to potential lack of fda approval, including dietary supplement for erectile dysfunction, dietary supplement for sexual enhancement and more. Additionally, there have been 26 drug and medical device recalls due to other health hazards as well as 94 food recalls.

Email Me About Recalls On:
Food  |  Drugs  |  Medical Devices  |  Pet Care Products  |  All of These


VitaliKoR Male Enhancement
Note: Images may not be available for every version. Please review the detailed description below.

Company Contact Information:

Name: Vitality Research Labs
Website: vitalikor.com
Phone: (855) 424-1954

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information



Regions Where Sold: Nationwide

Product Description: Dietary Supplement

Brand Name(s): VitaliKOR

Reason for Recall: Unapproved new drug

Official Recall Date: 2013-11-13

Note: Although this recall announcement is dated 11/13/2013, it was not published by the FDA until 11/14/2013.



Advertisement

Additional information provided by the FDA.gov:

Vitality Research Labs, LLC, Issues Immediate Voluntary Nationwide Recall of "VitaliKOR Fast Acting" Marketed as a Dietary Supplement, Due to Undeclared Active Ingredients


 

Contact:
Consumer:
(855) 424-1954 
Email: customercare@vitalikor 

  

FOR IMMEDIATE RELEASE - November 13, 2013 – Vitality Research Labs, LLC, the repackager of the VitaliKOR Products, is voluntarily recalling lots K58Q and F50Q of VitaliKOR Fast Acting to the consumer level. FDA laboratory analysis on VitaliKOR has determined that this product contains undeclared Vardenafil and Tadalafil. Vardenafil and Tadalafil are active ingredients of FDA-approved drugs used to treat erectile dysfunction (ED), making VitaliKOR Fast Acting an unapproved drug.

The undeclared active ingredients poses a threat to consumers because Vardenafil and Tadalafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to unsafe levels. Consumers with diabetes, high bl ood pressure, high cholesterol, or heart disease often take nitrates. Additionally, the product may cause side effects, such as headaches and flushing.

This product is marketed as an all-natural nutritional supplement for sexual enhancement and packaged in chip board exterior carton containing clear plastic bottles with forty (40) light blue capsules and were sold nationwide through various internet websites and at retail stores. The number of individual units affected by the recall is 66,090. The lots were produced in January and July of 2013. Vitality Research Labs has discontinued distribution and sales of these lots.

Consumers should not consume these lots of VitaliKOR Fast Acting and should return the products immediately to the place of purchase for credit. Vitality Research Labs, LLC is notifying its distributors and consumers by email and is arranging for credit of the entire recalled product. Consumers/distributors/retailers that have VitaliKOR for the lots identified for recall should return to place of purchase.

Consumers with questions regarding this recall should contact Vitality Research Labs at 1-855-424-1954 or via e-mail at customercare@vitalikor Monday - Friday, 8:30 am - 5:00 pm, PST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this unapproved drug. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Online: www.fda.gov/medwatch/report.htm
  • Regular Mail: use postage-paid, pre-addressed Form FDA 3500
    available at: www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.
  • Fax: 1-800-FDA-0178
  • This recall action is being conducted with the knowledge of the U.S. Food and Drug Administration.


    More information may be available at FDA.gov
    Advertisement


    Latest Safety Recalls

    Select image for details, including additional styles.

     

    Advertisement

    Comments

    Do you have comments or questions about this recall? Share them here.
    Note: The recalling companies may not be monitoring these comments; they should be directed toward the public. Community Guidelines apply.
    comments powered by Disqus
    Back to Top



    Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.

    Search Recalled Products or Browse by Category
    Consumer Products (?)
    Food & Health (?)
    Vehicles (?)
    Latest Product Recalls
    Consumers
    Register Products
    Check for Recalls
    Find Resources
    Brands & Retailers
    Connect to Customers

    Consignment Sales
    Check Inventory
    Install Recall Finder
    Take Safety Pledge

    Home Inspectors
    Check Appliances
    Developers
    APIs & Feeds
    Recall Search for Web
    Recall Search for Mobile
    Facebook Apps

    Researchers
    Product Recall Statistics
    About
    Company
    Contact
    Press
    Blog

    Social
    Facebook
    Twitter